Navigation Links
Abbott 'Goes Red' to Educate Bay Area Women About Heart Disease
Date:2/1/2008

Abbott Sponsors American Heart Association's 'Go Red for Women' Movement in

the Bay Area

SANTA CLARA, Calif., Feb. 1 /PRNewswire/ -- As a leader in cardiovascular treatment and the exclusive Bay Area "hometown" partner for the national "Go Red for Women" program, Abbott (http://www.abbott.com) is partnering with the American Heart Association (AHA) to raise awareness about heart disease, the leading cause of death for women in America.

One out of every three American women will die of heart disease, yet, according to AHA, only 13 percent of women believe heart disease is their greatest health risk. While largely preventable, heart disease in women often goes underdiagnosed and undertreated. Data shows that most women fail to make the connection between risk factors like high blood pressure and high cholesterol and their risk of developing heart disease.

Through this year-long campaign, which kicks off in February -- American Heart Month -- Abbott and AHA hope to raise awareness that even women without classic risk factors and symptoms may be at risk -- just ask Michelle Smietana, a software testing engineer at Abbott. Ironically, Michelle just had her blood pressure and cholesterol checked -- both were normal. While she used to smoke and had been a bit overweight, she was feeling strong and healthy so she didn't know what to suspect last spring when she experienced some back pain that crept into her neck. At just 33, both she and the cardiologist who treated her were shocked when her ultrasound results showed evidence of a heart attack.

"If heart disease can happen to me, it can happen to anyone. I was only

33, had low cholesterol and good blood pressure. I didn't have the

"normal" symptoms you associate with heart disease like left arm pain and

pressure in my chest. Going through cardiac rehabilitation helped make

exercise a regular part of my life and has helped repair the damage to my

heart. Through this campaign, I hope other women hear my story and take

steps to understand their risk for heart disease."

Michelle Smietana, of Abbott, 33-year-old heart attack victim

According to AHA, Michelle is not alone. Heart attacks strike 9,000 women younger than 45 each year.

To increase the awareness of this and other little known facts about heart disease, Dr. Sandra Burke, a scientist in the Santa Clara-based vascular division of Abbott, is dedicating her career and her free time to fighting heart disease.

"Abbott and AHA urge women to talk to their doctors about their risk of

heart disease and to start taking action to lead healthier lives."

Dr. Sandra Burke

Director, cardiovascular biology research, Abbott Vascular

In addition to raising awareness through campaigns like "Go Red," Abbott is committed to developing new drugs and medical devices to treat heart disease and related conditions. With diagnostic tests, pharmaceutical products, nutritional products and vascular stents to diagnose and treat heart disease, Abbott has one of the world's leading heart disease and vascular care businesses.

Abbott's CEO, Miles White, sent an e-mail to the company's 35,000 U.S. employees earlier today echoing this commitment.

"Abbott is in the fight against heart disease for the long haul and

through all the means at our disposal: with our diagnostic tests to

identify cardiovascular conditions, our pharmaceutical treatments to

improve patients' cardiovascular health, our nutritional products that

help to improve cardiovascular status, and our stents that relieve acute

vascular conditions by reopening blocked arteries. It's only natural that

we lend our philanthropic support and the skills and commitment of our

people, as well."

Miles D. White, chairman and chief executive officer, Abbott

Go Red Heart Checkup

Women throughout the Bay Area can register today for a free online heart checkup that predicts their personal risk of having a heart attack within 10 years. To register, visit GoRedForWomen.org.

About Abbott

Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacturing and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.

Related Links

Go Red for Women

[http://www.goredforwomen.org/]

Women, Heart Disease and Stroke, the American Heart Association

[http://www.americanheart.org/presenter.jhtml?identifier=4786]

American Heart Association

[http://www.americanheart.org/]


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Present at Merrill Lynch Healthcare Conference
2. Abbotts Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
3. Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2007 Earnings
4. Cookie Johnson and Abbott Bring I Stand With Magic: Campaign to End Black AIDS to Los Angeles to Educate African-American Women on HIV/AIDS
5. Ugandan Children Are Among the First to Receive Abbotts Lower-Strength Aluvia (lopinavir/ritonavir) Tablet
6. The Magic Johnson Foundation and Abbott Expand Focus of Campaign to End Black AIDS to African-American Women in 2008
7. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
8. Abbotts Environmental Protection Initiatives Again Recognized by the State of Illinois
9. Abbott Employees Give Back to Local Communities This Holiday Season
10. AUDIO from Medialink and Abbott Labs: Easing Holiday Stress for Families of Those With Diabetes
11. Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... , ... "I have gout, and I wanted to treat it naturally," said ... to relieve gout and pain caused by varicose veins. I drank it every morning ... relieved what VA doctors called the worst sinusitis case they'd seen and relieved gas, ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric ... patient safety. Only a few hospitals and facilities have earned this distinction. This ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the ... and Eric Hoessel to vice president of sales. , Litsinger joined Mirixa ...
(Date:12/8/2016)... ... 08, 2016 , ... SunView Software aims to redefine IT ... both engaging and easy to use. Coming off the heels of a successful ... its plans to roll out new AI-powered self-service enhancements to help organizations implement ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 9, 2016 Research and Markets has ... report to their offering. ... The report forecasts the global optical transceiver market ... The report covers the present scenario and the ... calculate the market size, the report considers the revenue generated from ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company ... severe, rare diseases, today announced that senior management will participate in ... Conference at the InterContinental Barclay Hotel in New York ... ET. About aTyr Pharma ... aTyr Pharma is engaged in the ...
(Date:12/9/2016)... Bermuda , Dec. 9, 2016  Axovant ... leading clinical-stage biopharmaceutical company focused on the treatment ... the data from a Phase 2b trial evaluating ... care donepezil, compared with donepezil plus placebo in ... that the addition of intepirdine to treatment was ...
Breaking Medicine Technology: